19 December 2019 | News
Certificate of Compliance issued by the European regulator, SUKL, Czech Republic for Glenmark’s Baddi manufacturing facility
Glenmark Pharmaceuticals has announced that its Baddi manufacturing unit has received Good Manufacturing Practice (GMP) certificate from European regulator State Institute for Drug control (SUKL).
Glenmark Pharmaceuticals said in statement that, “The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO.”
“Baddi manufacturing unit of Glenmark Pharmaceuticals was inspected by the leading European regulator, SUKL (State Institute for Drug control), Czech Republic in the week of Oct 21, 2019.”The company statement added.